New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
08:36 EDTHTWRHeartWare shares recommended at Canaccord
Canaccord recommends increasing exposure to HeartWare. The firm expects HeartWare to have a very strong 2013 and notes checks in the U.S. indicate upside to current estimates. The firm rates shares a Buy and raised its price target to $144 from $107.
News For HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
07:53 EDTHTWRHeartWare downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
07:36 EDTHTWRHeartWare downgraded to Neutral from Buy at BTIG
Subscribe for More Information
September 1, 2015
16:21 EDTHTWRHeartWare agrees to acquire Valtech Cardio
HeartWare announced that it has entered into a definitive agreement to acquire Valtech Cardio. According to the terms of the agreement, Valtech shareholders will receive an up-front consideration of 4.4M shares of HeartWare common stock; 800,000 shares of HeartWare common stock, contingent upon CE Mark approval for Cardioband; and 700,000 shares of HeartWare common stock upon the earlier of first-in-man implants for either Cardioband tricuspid or CardioValve. The transaction also includes warrants to purchase 850,000 shares of HeartWare common stock at an exercise price of $83.73 per share exercisable upon attainment of $75M in net sales of Valtech products, and an earn-out payment of $375M, upon attainment of $450M of net sales of Valtech products. This transaction was approved by the boards of HeartWare and Valtech, with holders of more than 70% of Valtech's shares having signed support agreements committing to the transaction. The transaction is subject to regulatory approvals, as well as HeartWare stockholder and Valtech shareholder approvals. The closing of the transaction is expected in late 2015.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use